Which serum tests are recommended to determine menopause in a woman with suspected menopause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Testing for Menopause Determination

In most women over age 45 with typical symptoms, menopause is a clinical diagnosis based on 12 months of amenorrhea—no blood testing is needed or recommended. 1

When Blood Testing Should Be Considered

Blood testing is only indicated in specific clinical scenarios, not for routine menopause diagnosis:

Appropriate Testing Situations:

  • Women aged 40-45 years with menopausal symptoms 2
  • Women under age 40 with suspected premature menopause 2
  • Women after hysterectomy (where amenorrhea cannot be assessed) 1
  • Women on hormonal contraception where clinical assessment is obscured 1

Recommended Tests and Interpretation

When testing is indicated, the following approach should be used:

Primary Markers:

  • FSH ≥40 IU/L combined with estradiol <20 pg/mL suggests menopausal status 1
  • For women on oral contraceptives: measure on day 7 of the pill-free interval 3

Important Caveats:

  • FSH alone is not sensitive for menopause diagnosis, particularly in women using oral contraceptives—62.5% of menopausal women still had FSH <30 IU/L on day 7 of the pill-free interval 3
  • FSH:LH ratio >1 may be more reliable than FSH alone 3
  • Repeat testing (at least 3 months apart) is recommended for women with hysterectomy to confirm menopausal status 1

Clinical Scenarios Where Testing Is NOT Recommended

Women on Hormonal Contraception:

  • Do not use hormonal assays or pelvic ultrasound to diagnose menopause in women using combined oral contraceptives, progestin-only pills, implants, or levonorgestrel IUDs 1
  • Recommended strategy: discontinue contraception, remove implant/IUD, and follow clinically for amenorrhea 1

After Cancer Treatment:

  • In women who received gonadotoxic chemotherapy, 12 months of amenorrhea cannot reliably diagnose menopause 1
  • No examination can definitively diagnose menopause in this population 1
  • For breast cancer patients, use the pre-treatment hormonal status when selecting endocrine therapy 1

Common Pitfalls to Avoid

  1. Over-testing in typical cases: The vast majority of women >45 years with amenorrhea and symptoms do not need blood work
  2. Single FSH measurement: One elevated FSH does not confirm menopause; levels fluctuate during perimenopause
  3. Testing while on hormonal contraception: Results are unreliable and should not guide clinical decisions
  4. Assuming amenorrhea equals menopause post-chemotherapy: This population requires different assessment strategies

The evidence consistently demonstrates that clinical diagnosis remains superior to laboratory testing for most women, with blood tests reserved for atypical presentations or when clinical assessment is impossible 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.